ADGRB1

Across TCGA pan-cancer cohorts, ADGRB1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ADGRB1 data layer compared with 25 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ADGRB1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ADGRB1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and COAD show a favorable association.

UCEC, COAD, and READ are the cancer types where ADGRB1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.970	0.623	.007	18	view →
COAD	DFS	Median	All	0.922	0.452	.015	10	view →
READ	OS	Median	III,IV	0.616	0.917	.003	7	view →
ESCA	DFS	Median	All	0.210	0.510	.014	6	view →
SKCM	DFS	Median	II,III,IV	1.000	0.687	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ADGRB1–UCEC (DFS)

Open the UCEC breakdown →